Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Enhanced evasion of neutralizing antibody response by Omicron XBB.1.5, CH.1.1, and CA.3.1 variants

Cell Reports(2023)10.1016/j.celrep.2023.112443Source: DataRank Database

Enhanced evasion of neutralizing antibody response by Omicron XBB.1.5, CH.1.1, and CA.3.1 variants is a research paper published in Cell Reports (2023). On theSindex it has a DataRank of 0. It has been cited 191 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access191 citations

Download PDF

Cite:

Linked data & code

cellosaurus pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 32.41)OA: goldTopics (44)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (17)

Julia N. Faraone ORCID,John P. Evans ORCID,Yi-Min Zheng ORCID,Claire Carlin ORCID,Mirela Anghelina

Live enrichment

PubMed:37104089 PMC:PMC10279473 OpenAlex:https://openalex.org/W4366287746

National Cancer Institute

Grant: U54CA260582

NIAID

Grant: U01 AI173348

National Institutes of Health

Grant: UH2 AI171611

NICHD NIH HHS

Grant: R01 HD095881

Center for Clinical and Translational Science, Ohio State University

College of Veterinary Medicine, Ohio State University

FWCI

32.41

Citation Percentile

1.0%

Influential Citations

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttp://www.cell.com/article/S2211124723004540/pdf

GOLDhttps://www.cell.com/article/S2211124723004540/pdf

publisherhttp://www.cell.com/article/S2211124723004540/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2211124723004540?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2211124723004540?httpAccept=text/plain

Fields of Study

SARS-CoV-2 and COVID-19 ResearchViral Infectious Diseases and Gene Expression in InsectsBacillus and Francisella bacterial researchMedicineBiologyAntibodies, NeutralizingAntibodies, MonoclonalAntibody FormationMutationRNA, MessengerVaccines, CombinedAntibodies, Viral

MeSH Terms

Antibodies, MonoclonalAntibodies, ViralAntibody FormationMutationRNA, MessengerVaccines, CombinedAntibodies, Neutralizing

Keywords

NeutralizationBivalent (engine)Neutralizing antibodyAntibodyMonoclonal antibodyChemistryMessenger RNAVirologyImmune escapeMolecular biologyBiologyImmune systemGeneImmunologyBiochemistryMetalImmune EvasionFusogenicityCp: MicrobiologyCp: ImmunologyOmicron SubvariantsXbb.1.5Ca.3.1Ch.1.1Mab S309

Sustainable Development Goals

SDG 0: Good health and well-being